title: Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
abstract: We describe a boy with an early lethal hypertrophic vacuolar cardiomyopathy of neonatal onset. Abnormal intra- and extralysosomal glycogen storage disease was demonstrated in heart and skeletal muscles. Glycogen content was twice the normal in muscles and over 3-fold the normal in the heart. In this organ, over 50% of the intracellular space was occupied by glycogen and possibly oligosaccharides, as demonstrated by the quantitative morphometric analysis of electron micrographs. The activity of acid alpha-glucosidase was increased in the heart, skeletal muscles, and liver, but was normal in leukocytes. A review of the 11 previously published pedigrees of lysosomal glycogen storage disease with normal in vitro alpha-glucosidase activity allows the delineation of three clinical entities: juvenile and neonatal pseudo-Pompe diseases and partial Pompe disease. Partial Pompe disease, due to the tissue-specific absence of acid alpha-glucosidase, was observed in a single patient. The most common form is the late-onset pseudo-Pompe disease, which is characterized by severe cardiomyopathy and mild myopathy appearing in the second or third decade, prominent arrhythmia with Wolf-Parkinson-White syndrome, and sometimes mental retardation. Patients reported as suffering from Antopol disease probably belong to this group. Dominant inheritance (autosomal or X linked) is likely in most families. The present report appears to be the first one to describe a rapidly fatal neonatal form of lysosomal glycogenosis without acid maltase deficiency. The mode of inheritance of this form is not known. Differential diagosis includes Pompe disease (similar histology) and cardiac phosphorylase b kinase deficiency (similar clinical course). The delineation of neonatal pseudo-Pompe disease makes enzymatic confirmation mandatory in each case suspected of Pompe disease.
authors.affiliation: Walloon University Centre For Human Genetics, Liège University, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Verloes
authors.forename: M
authors.initials: M
authors.lastname: Massin
authors.forename: J
authors.initials: J
authors.lastname: Lombet
authors.forename: B
authors.initials: B
authors.lastname: Grattagliano
authors.forename: D
authors.initials: D
authors.lastname: Soyeur
authors.forename: J
authors.initials: J
authors.lastname: Rigo
authors.forename: L
authors.initials: L
authors.lastname: Koulischer
authors.forename: F
authors.initials: F
authors.lastname: Van Hoof
mesh_terms: D005087:Glucan 1,4-alpha-Glucosidase / Q000172:deficiency; D006009:Glycogen Storage Disease Type II / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D006801:Humans; D007231:Infant, Newborn; D016464:Lysosomal Storage Diseases / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D009206:Myocardium / Q000648:ultrastructure; D010375:Pedigree; D000520:alpha-Glucosidases
chemical_list: D000520:alpha-Glucosidases; D005087:Glucan 1,4-alpha-Glucosidase